Projects per year
Fingerprint
Dive into the research topics where Daniel Whitcomb is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
Research output
-
Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β
Jo, J., Whitcomb, D. J., Olsen, K. M., Kerrigan, T. L., Lo, S-C., Bru-Mercier, G., Dickinson, B., Scullion, S., Sheng, M., Collingridge, G. & Cho, K., May 2011, In: Nature Neuroscience. 14, 5, p. 545 - 547 3 p.Research output: Contribution to journal › Article (Academic Journal) › peer-review
259 Citations (Scopus) -
Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization
Li, Z., Jo, J., Jia, J. M., Lo, S. C., Whitcomb, D., Jiao, S., Cho, K. & Sheng, M., 28 May 2010, In: Cell. 141, 5, p. 859 - 871 13 p.Research output: Contribution to journal › Article (Academic Journal) › peer-review
440 Citations (Scopus) -
AZD5438 a GSK-3a/b and CDK inhibitor is antiapoptotic modulates mitochondrial activity and protects human neurons from mitochondrial toxins
Shi, G., Scott, H., Azhar, N. I. F. M., Gialeli, A., Clennell, B., Lee, K. S., Hurcombe, J., Whitcomb, D., Coward, R., Wong, L-F., Cordero-Llana, O. & Uney, J. B., 23 May 2023, In: Scientific Reports. 13, 1, 13 p., 8334 (2023).Research output: Contribution to journal › Article (Academic Journal) › peer-review
Open Access